Cartalax (25mg)

Caratalx is a short, highly specialized bioregulatory peptide complex aimed at supporting cartilage, joint, and connective tissue health through modulation of fibroblast activity, control of matrix degradation, and promotion of cellular resilience. As with other experimental peptides, it is intended for laboratory or research use and not for direct clinical or over-the-counter therapeutic use.

$80.00

Quantity Discount (%) Price
1 - 3 $80.00
4 - 9 6 % $75.20
10+ 12 % $70.40
x

This product remains in its original powdered state without being reconstituted.

Caratalx (Cartalax / AED / T-31 Peptide Complex)

Bioregulatory Peptide Blend for Musculoskeletal & Connective Tissue Support

Overview

Caratalx, also known as Cartalax, AED, or T-31, is a synthetic tripeptide (Alanine-Glutamic acid-Aspartic acid) complex designed to support cartilage integrity, joint function, and connective tissue health. This bioregulatory peptide is sometimes marketed for its potential to normalize cartilage tissue activity, modulate fibroblast behavior, and promote structural resilience in musculoskeletal systems. 


Mechanism & Biological Activity

Though research is still preliminary, available data and product references suggest Caratalx may work through:

  • Modulation of fibroblast signaling and gene expression, affecting the balance of cell proliferation, apoptosis, and senescence 

  • Reduction of pro-degradative enzymes such as matrix metalloproteinases (e.g., MMP-9), which degrade extracellular matrix components in aging tissues 

  • Support of cartilage cell (chondrocyte) function and matrix synthesis, potentially by influencing collagen and proteoglycan dynamics 

  • Anti-apoptotic and cell survival effects via suppression of caspase activity, reduction in p53 signaling, and boosting proliferation markers (e.g., Ki-67) in aging or stressed cells 


Specifications & Formulation

  • Peptide Sequence: Ala-Glu-Asp (AED) 

  • Molecular Formula: C₁₂H₁₉N₃O₈ 

  • Molecular Weight: ~333.29 g/mol 

  • Purity: Often claimed ≥ 99% (depending on supplier) 

  • Physical Form: Lyophilized powder (vials) for reconstitution 

  • Storage & Handling: Requires cold storage; reconstitution with sterile bacteriostatic water; avoid repeated freeze cycles 


Potential Applications & Use Cases

Caratalx is most often positioned in research and experimental settings focused on:

  • Joint health and cartilage repair

  • Osteoarthritis, chondropathy, degenerative joint diseases 

  • Connective tissue support and regeneration

  • Anti-aging / geroprotective research, especially in connective and extracellular matrix systems 

  • Post-injury recovery of cartilage or joint tissues

 

PRODUCTS ARE FOR RESEARCH PURPOSES ONLY

Related Products